The mTOR homeostatic window in kidney disease

Introduction Mechanistic target of rapamycin (mTOR) signaling is both essential for renal cellular homeostasis and a driver of pathological remodeling when persistently activated. This paradox is especially evident in podocytes, where excessive mTOR complex 1 (mTORC1) activity promotes hypertrophy, metabolic stress, proteinuria, and fibrosis, whereas excessive suppression can destabilize the filtration barrier. Methods We review cell- and context-specific functions of mTORC1 and mTOR complex 2 (mTORC2) across kidney disease, including podocytopathies, chronic kidney disease, acute kidney injury-to-chronic kidney disease transition, and transplantation. Results We propose that the therapeutic objective should shift from global mTOR inhibition toward precision modulation defined by cell identity, molecular complex, dose, disease stage, and duration. Podocyte-targeted everolimus delivery provides preclinical support that spatial restriction can reshape pathway effects and raises the hypothesis that it could widen the therapeutic window. Discussion This homeostatic window theory may guide safer antifibrotic and glomerular therapies.

Authors

Institutions

Publication Details

Journal
Frontiers in Nephrology
Published
2026-11-18
DOI
https://doi.org/10.3389/fneph.2026.2008149
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The mTOR homeostatic window in kidney disease

Kui Fan, Li Zeng, Lanxing Zhou, Maozhi Tang et al.
Frontiers in Nephrology
Renal Diseases and Glomerulopathies
article

The mTOR homeostatic window in kidney disease

Kui Fan, Li Zeng, Lanxing Zhou, Maozhi Tang, Yuan Yu, Qin Zhou
article en

Abstract

Introduction Mechanistic target of rapamycin (mTOR) signaling is both essential for renal cellular homeostasis and a driver of pathological remodeling when persistently activated. This paradox is especially evident in podocytes, where excessive mTOR complex 1 (mTORC1) activity promotes hypertrophy, metabolic stress, proteinuria, and fibrosis, whereas excessive suppression can destabilize the filtration barrier. Methods We review cell- and context-specific functions of mTORC1 and mTOR complex 2 (mTORC2) across kidney disease, including podocytopathies, chronic kidney disease, acute kidney injury-to-chronic kidney disease transition, and transplantation. Results We propose that the therapeutic objective should shift from global mTOR inhibition toward precision modulation defined by cell identity, molecular complex, dose, disease stage, and duration. Podocyte-targeted everolimus delivery provides preclinical support that spatial restriction can reshape pathway effects and raises the hypothesis that it could widen the therapeutic window. Discussion This homeostatic window theory may guide safer antifibrotic and glomerular therapies.

Frontiers in NephrologyVol. 6
Chongqing University (CN), Second Affiliated Hospital of Chongqing Medical University (CN), Chongqing Emergency Medical Center (CN)
Good health and well-being
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon